ListarEnfermidades endocrinas, nutricionais e metabólicas por tema "Sibutramine"
Mostrando ítems 1-1 de 1
-
Approved and off-label uses of obesity medications, and potential new pharmacologic treatment options
(MDPI, 2010-01-12)[Abstract] Available anti-obesity pharmacotherapy options remain very limited and development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake by ...